FDA Inspection 1227815 — Optikem International, Inc.

Optikem International, Inc. — FEI 1720129

The FDA completed an inspection of Optikem International, Inc. on Jan 26, 2024 in Denver, CO. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 14 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Jan 26, 2024
Fiscal Year
2024
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Denver, CO (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
121521 CFR 211.67(b)Written procedures not established/followed
136121 CFR 211.100(a)Absence of Written Procedures
143621 CFR 211.42(c)(10)(vi)Equipment to control conditions
145121 CFR 211.113(b)Procedures for sterile drug products
145221 CFR 211.113(b)Validation lacking for sterile drug products
192021 CFR 211.166(a)(3)Valid stability test methods
200921 CFR 211.188Prepared for each batch, include complete information
202721 CFR 211.192Investigations of discrepancies, failures
220521 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
358521 CFR 211.110(a)Control procedures to monitor and validate performance
360321 CFR 211.160(b)Scientifically sound laboratory controls